Sign up to save your podcasts
Or
Share The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
CME credits: 0.25
Valid until: 26-01-2025
Claim your CME credit at https://reachmd.com/programs/cme/the-beat-goes-on-new-data-on-improving-symptoms-in-hfref-patients-using-novel-device-therapy/14474/
Even with guideline-directed medical therapy, or GDMT, many patients with heart failure are limited in their daily activities, due to increasing symptoms and reduced functionality. However, new data from BeAT-HF, a clinical trial that examines the long-term effects of baroreflex activation therapy, or BAT, shows that BAT may provide patients with sustained and durable benefits in exercise capacity, functional status, and quality of life.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 26-01-2025
Claim your CME credit at https://reachmd.com/programs/cme/the-beat-goes-on-new-data-on-improving-symptoms-in-hfref-patients-using-novel-device-therapy/14474/
Even with guideline-directed medical therapy, or GDMT, many patients with heart failure are limited in their daily activities, due to increasing symptoms and reduced functionality. However, new data from BeAT-HF, a clinical trial that examines the long-term effects of baroreflex activation therapy, or BAT, shows that BAT may provide patients with sustained and durable benefits in exercise capacity, functional status, and quality of life.
=